Targeting gut microbiota with dietary components on cancer: Effects and potential mechanisms of action
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Cancers are common chronic diseases worldwide and cause severe health burdens. There have been ongoing debates on the role of gut microbiota in the prevention and management of cancers, thus, it is worthwhile to pay high attention to the impacts of gut microbiota on several cancers, such as colon, liver, and breast cancers. In addition, it has been reported that gut microbiota may also affect the efficacy of cancer chemotherapy and immunotherapy. Among all the factors that influence gut microbiota, diet is the most influential and modifiable. The prebiotics, dietary fibers, short-chain fatty acids, and other bioactive compounds are all important dietary components to assist the growth of beneficial microbiota in the gut, which can protect against cancers and promote human health. Their beneficial effects can be due to the fermentation of dietary fibers, the metabolism of phytochemicals, the synthesis of estrogens, and interactions with chemotherapies and immunotherapies. In order to provide updated information of the relationships among dietary components, gut microbiota, and cancer, in this review, we summarize the reciprocal interactions between dietary components and gut microbiota, and highlight the impacts of dietary components on several common cancers by targeting gut microbiota, with the potential mechanisms of actions also intensively discussed. As a result, this review can be very helpful for healthy people as well as cancer patients to prevent or manage cancers via dietary factor-mediated regulation of gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597 · cited 1×
“…and their metabolites are positively or negatively associated with obesity, metabolic syndromes, and inflammatory bowel diseases (IBD), which are correlated with increased cancer risk (Gentschew and Ferguson 2012; Karlsson et al. 2013; Liu et al. 2017; Menni et al. 2018; Wang et al. 2011).”
BackgroundThe Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888 · cited 2×
“Similarly, oral administration of Bifidobacterium controls tumor developments even as significantly as the PD-L1-specific antibody therapy, and a combination of Bifidobacterium and PD-L1 therapy nearly abolishes tumor growth in C57BL/6 mice (Sivan et al. 2015).”
BackgroundThe impact of the gut microbiota on human health: an integrative view
Clemente, J. C., Ursell, L. K., Parfrey, L. W., & Knight, R. (2012) · Cell · doi:10.1016/j.cell.2012.01.035 · Cited by 3,710 · cited 1×
“…microbiota Although gut flora remain stable over time, many factors can influence the composition and abundance of gut microbiota, including heredity, age, region, lifestyle, and diet, among which diet is the most influential and modifiable factor (Clemente et al. 2012; Clements and Carding 2018).”
BackgroundAnticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488 · cited 2×
“T cell response specific for B. thetaiotaomicron or B. fragilis is associated with CTLA-4 blockade efficacy, and tumors in germ-free or antibiotic-treated mice exhibit no response to CTLA-4 blockade (Vetizou et al. 2015).”
BackgroundGut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314 · cited 1×
“Besides, a study of 178 elder subjects demonstrates that the diversity of healthy food intake is positively associated with microbial diversity, indicating that a healthy diet with multiple choices of foods can promote a more balanced gut microbiota (Claesson et al. 2012).”
BackgroundRegulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241 · cited 1×
“Gut microbiota-mediated generation of SCFAs possess several health benefits, which is shown in Figure 2, including maintaining mucosal integrity and suppressing inflammation through G protein-coupled receptors (GPCRs), such as GPCR41, GPCR43, and GPCR109A (Maslowski et al. 2009; Smith et al. 2013).”
BackgroundShort chain fatty acids in human large intestine, portal, hepatic and venous blood
Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P., & Macfarlane, G. T. (1987) · Gut · doi:10.1136/gut.28.10.1221 · Cited by 3,119
Gut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115 · cited 1×
“…and their metabolites are positively or negatively associated with obesity, metabolic syndromes, and inflammatory bowel diseases (IBD), which are correlated with increased cancer risk (Gentschew and Ferguson 2012; Karlsson et al. 2013; Liu et al. 2017; Menni et al. 2018; Wang et al. 2011).”
Background
Cited by
Human gut microbiota in health and disease: Unveiling the relationship
Afzaal, M., Saeed, F., Shah, Y. A., Hussain, M., Rabail, R., Socol, C. T., Hassoun, A., Pateiro, M., Lorenzo, J. M., Rusu, A. V., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.999001 · Cited by 762
Health Benefits and Side Effects of Short-Chain Fatty Acids
Xiong, R.-G., Zhou, D.-D., Wu, S.-X., Huang, S.-Y., Saimaiti, A., Yang, Z.-J., Shang, A., Zhao, C.-N., Gan, R.-Y., & Li, H.-B. (2022) · Foods · doi:10.3390/foods11182863 · Cited by 466
Self-citationCausal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study
Long, Y., Tang, L., Zhou, Y., Zhao, S., & Zhu, H. (2023) · BMC Medicine · doi:10.1186/s12916-023-02761-6 · Cited by 401
Effects and Mechanisms of Resveratrol on Aging and Age‐Related Diseases
Zhou, D.-D., Luo, M., Huang, S.-Y., Saimaiti, A., Shang, A., Gan, R.-Y., & Li, H.-B. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9932218 · Cited by 363
Self-citationDietary patterns and cancer risk
Steck, S. E., & Murphy, E. A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0227-4 · Cited by 292
Metadata
- Authors
- Tao, J., Li, S., Gan, R.-Y., Zhao, C.-N., Meng, X., & Li, H.-B.
- Venue
- Critical Reviews in Food Science and Nutrition
- Publisher
- Informa UK Limited
- Published
- 2019-01-11
- Volume
- 60
- Issue
- 6
- Pages
- 1025-1037
- ISSN
- 1040-8398 (ISSN-L)
- 1549-7852
- OpenAlex
- W2909740547
- Cited by
- 119
- References
- 44
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting gut microbiota with dietary components on cancer: Effects and potential mechanisms of action. https://app.cochat.ai/papers/10.1080/10408398.2018.1555789
- The paper
- Tao, J., Li, S., Gan, R.-Y., Zhao, C.-N., Meng, X., & Li, H.-B. (2020). Targeting gut microbiota with dietary components on cancer: Effects and potential mechanisms of action. Critical Reviews in Food Science and Nutrition. https://doi.org/10.1080/10408398.2018.1555789
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.